New England Journal of Medicine· 2025Q1
DB-OTO Gene Therapy for Inherited Deafness
- 66citations
- Q1SCImago
- 2025year
Short summary
DB-OTO gene therapy, delivering the OTOF gene, restored hearing to a level enabling natural acoustic hearing in 75% (9 of 12) of children with congenital deafness due to otoferlin deficiency.
AI-generated from the title and abstract; the full text is not read.
TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app
The rest is in the Pofolia app
Takeaways, key points and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Sensory Systems
Sensory SystemsNeuroscience